Haribo Cannabis Recall Overview
Haribo confirmed a voluntary recall of specific cannabis-infused gummy products after a regulatory audit identified potential contamination and labeling discrepancies. The recall targeted limited production batches distributed through licensed dispensaries in select U.S. states. Haribo stated the issue was detected during internal quality control checks and that no consumer injuries had been reported at the time of the announcement. The company initiated a full traceability review of its supply chain partners to isolate the source of the discrepancy.
The affected products were primarily THC-infused gummy bears and rings sold under a licensed collaboration brand. Regulatory filings show the recall was classified as a Class II health risk, meaning the product could cause temporary or medically reversible adverse effects. Haribo issued a public notice urging consumers to check batch codes on packaging and return any affected units to the point of purchase. The recall was coordinated with state cannabis control boards and the relevant federal oversight bodies.
Scope of the Haribo Cannabis Recall
Haribo disclosed that the recall covered products shipped between the first and third quarters of the current fiscal year. The company identified 14 distribution centers and 23 retail partners that received the affected lots. Haribo set up a dedicated consumer hotline and an online batch verification portal to help customers confirm whether their products were part of the recall. The total estimated retail value of the recalled inventory was reported at approximately $4.7 million.
Independent lab tests conducted by a third-party facility confirmed that some batches contained inconsistent THC concentrations, with deviations exceeding the labeled potency by up to 18 percent. Haribo stated that all products were manufactured at a single facility and that the issue was traced to a temporary calibration error in the dosing equipment. The company announced a facility-wide equipment audit and implemented additional in-process quality checks before resuming production of the affected line.
Market Impact and Regulatory Response
Following the Haribo cannabis recall, shares of the parent holding company dropped by 2.3 percent in after-hours trading on the day of the announcement. Analysts noted that the recall could affect Haribo's market share in the cannabis edibles segment, where competition from established brands has intensified. The company's stock price had already faced pressure due to broader supply chain disruptions and regulatory scrutiny in the U.S. cannabis market.
State regulators in California, Colorado, and Michigan opened preliminary reviews of the recall and requested detailed documentation from Haribo. The U.S. Food and Drug Administration confirmed it was coordinating with state agencies but did not issue a federal enforcement action at this stage. Haribo has committed to submitting a corrective action plan within 30 days and to quarterly compliance updates for the next two fiscal quarters.